-
Capsules
Generic Name & Amount | Pack Sizes | Indications |
---|---|---|
Each capsule contains: Silymarin (micronized) 140 mg. standardized to a content of more than 45% Silybin in the Form/ Formsof dry standardized extract of Milk Thistle (Silybum marianum). | Capsules: 1 x 10 tabs 3 x 10 Tabs | • Acute and chronic viral hepatitis. • Chronic active hepatitis. • Non-alcoholic steato-hepatitis (NASH). • Steatosis (fatty liver). • Liver cirrhosis. • Primary biliary cirrhosis. • Alcoholic liver disease. • Liver injury induced by drugs (e.g. paracetamol and general anaesthetics). • Liver intoxication due to substances present in the working environment. • Cholestatic liver disease. |




-
Capsules
GENERIC NAME & AMOUNT
Each capsule contains:
Silymarin (micronized) 140 mg.
standardized to a content of more than 45% Silybin in the Form/ Formsof dry standardized extract of Milk Thistle (Silybum marianum).
PACK SIZES
Capsules:
1 x 10 tabs
3 x 10 Tabs
INDICATIONS
- Acute and chronic viral hepatitis.
- Chronic active hepatitis.
- Non-alcoholic steato-hepatitis (NASH).
- Steatosis (fatty liver).
- Liver cirrhosis.
- Primary biliary cirrhosis.
- Alcoholic liver disease.
- Liver injury induced by drugs (e.g. paracetamol and general anaesthetics).
- Liver intoxication due to substances present in the working environment.
- Cholestatic liver disease.
-
Suspension
Generic Name & Amount | Pack Sizes | Indications |
---|---|---|
Each 100 ml suspension contains: Silymarin (micronized) 1 gm. Standardized to a content of more than 45% silybin. | Suspension: Bottle 120 Ml | • Acute and chronic viral hepatitis. • Chronic active hepatitis. • Non-alcoholic steato-hepatitis (NASH). • Steatosis (fatty liver). • Liver cirrhosis. • Primary biliary cirrhosis. • Alcoholic liver disease. • Liver injury induced by drugs (e.g. paracetamol and general anaesthetics). • Liver intoxication due to substances present in the working environment. • Cholestatic liver disease. |


-
Suspension
GENERIC NAME & AMOUNT
Each 100 ml suspension contains:
Silymarin (micronized) 1 gm.
standardized to a content of more than 45% silybin.
PACK SIZES
Suspension:
Bottle 120 Ml
INDICATIONS
- Acute and chronic viral hepatitis.
- Chronic active hepatitis.
- Non-alcoholic steato-hepatitis (NASH).
- Steatosis (fatty liver).
- Liver cirrhosis.
- Primary biliary cirrhosis.
- Alcoholic liver disease.
- Liver injury induced by drugs (e.g. paracetamol and general anaesthetics).
- Liver intoxication due to substances present in the working environment.
- Cholestatic liver disease.